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Design and Development of Platforms for the Application of Loop-mediated Isothermal Nucleic 
Acid Amplification, LAMP, in the Diagnosis of Polymicrobial Diseases 
Tochukwu Dubem Anyaduba, Travis Schlappi (PI) 
 
For the past two decades, several isothermal nucleic acid amplification technologies have emerged. 
These are mostly in response to the need for robust molecular diagnostic tools amenable to point-
of-care and limited-resource settings. Of these, loop-mediated isothermal amplification, LAMP, 
stands out as a highly specific and rapid alternative to the polymerase chain reaction, PCR. One of 
LAMP's significant characteristics involves using four essential and two loop (rate increasing) 
primers to recognize six to eight (6 – 8) distinctive regions in a target DNA sequence. While the 
assortment of primers makes LAMP highly specific, it also poses a challenge to its exploitation in 
multiplex molecular diagnostics. Several published methods present means of adopting LAMP in 
multiplexing; however, only very few can detect up to four targets within the same sample stream. 
Our research's overall goal is to develop platforms capable of exploiting LAMP's high degree of 
specificity in identifying 9+ pathogens within the same sample stream using rapid prototyping/ 
simplistic technologies. This goal is fundamental in diagnosing polymicrobial diseases such as 
urinary tract infections, diarrheal diseases, respiratory tract infections, and other diseases whose 
attendant symptoms compel uninformed prescriptions. To meet this need, we designed multiple 
methods and developed unit processes toward achieving a more promising platform, A Primer 
Payload Platform (P3). The P3 is borne out of the ideology that the isolation of LAMP primer sets 
and their specific target DNA moieties in micro-reaction vesicles from a single reaction mix could 
aid the differential detection of multiple targets without the limitations attendant to current 
multiplexing systems. Thus, as a first step toward achieving the P3, we adopted methods for a 
multifaceted use of beads (as pathogen identity signatures, primer-delivery machinery, and specific 
target DNA carriers). Secondly, we employed simplistic rapid prototyping methodologies to 
develop microfluidic cartridges to generate highly monodisperse picoliter-scale droplets. As these 
droplets are digital-LAMP and digital PCR-ready, we further applied them to detect and quantify 
Escherichia coli and Lactobacillus acidophilus genomic DNA. Finally, we developed a 
mechanism for the encapsulation of the beads in picoliter-scale droplets. By unifying the droplet 
 
 
formation and bead introduction rates at the flow-focusing junction, we recorded more single-
bead-carrying droplets than predicted by Poisson statistics. While we do not have a perfect system 
for single-particle encapsulation, we achieved higher single bead encapsulation than ever reported 
in systems using rapid prototyping for microfluidics or dense bead manipulation. 
Our vision is to fully integrate these unit processes into a unified microfluidics-based platform for 
polymicrobial diseases molecular diagnostics at the point of care. We believe this platform will 
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Chapter 1: Introduction and Scope of Thesis 
 
The Big Picture 
 
Medical diagnostics drives about 70% of health care interventions1,2. Without more precise and 
targeted interventions, by the year 2050, the world will lose 10 million lives annually due to 
antimicrobial resistance3. This forecast puts a toll on healthcare professionals as well as researchers 
to develop more effective antimicrobial agents. More importantly, it underscores the lacuna in 
infectious disease diagnostic efficiency as a means of improving antimicrobial stewardship. It also 
stresses the importance of timely interventions, pathogen escape mitigation, and a focus on limited-
resource settings that experience higher disease burden. As a yardstick for measuring the 
achievement of these diagnostic milestones, the WHO instituted the ASSURED (affordable, 
sensitive, specific, user-friendly, rapid and robust, equipment-free, and deliverable to the end-
user)4 criteria, thus emphasizing the importance of inexpensive and simplistic molecular diagnostic 
platforms. 
 
Unfortunately, the gold standard in infectious disease diagnostics remains the propagation, 
isolation, and identification of the etiologic agent(s), perhaps using microbiological techniques. 
Although this technique has been used successfully since Robert Koch and Martinus Beijerinck5, 
its application is limited to only etiologic agents cultured in controlled environments (e.g., culture 
media). Because of the multiple time-prohibitive steps, successful application of this technique in 
medical diagnostics often takes between 2 to 4 days for mono-pathogenic diseases and more for 
polymicrobial infectious diseases. Handling also requires advanced training and containment 
infrastructure, making it unfit to solve the re-emerging challenges that require timely interventions.   
Some of these challenges were solved by the advent of culture-independent diagnostic methods 
such as immunoassays (enzyme-linked immunosorbent assay - ELISA, enzyme-multiplied 
immunoassay technique - EMIT), matrix-assisted laser desorption/ionization-time of flight 
(MALDI-TOF), Biochemical assays (e.g., catalase test, Voges Proskauer), flow cytometry, and 
most importantly, nucleic acid (NA) amplification such as quantitative polymerase chain reaction 





Owing to the specificity of nucleic acid amplification and testing (NAAT) methods compared to 
other culture-independent methods and its wide application, NAAT remains the method of choice 
with PCR as its gold standard9,10. Unfortunately, although qPCR is successful in detecting as little 
as ~100 fg of target DNA in a sample stream11, its demerits include its complexity, energy 
demand,12 instrument cost (between $49 – $80k)13, slow turnaround time compared to isothermal 
methods, and its sensitivity to sample matrix. These make qPCR less attractive for use at point-of-
care or limited-resource settings, thus favoring iNAT14. 
 
iNAT technologies became attractive due to their low complexity, rapid turnaround time,  low-
cost, high amplicon yield15. They also have low energy demand – as amplification is carried out at 
a single temperature, thereby eliminating the need for complex thermal cycling instrumentation.16 
These attributes also made them amenable for use in point-of-care settings. Unlike qPCR, several 
modifications or technologies exist under iNAT. These include NASBA (nucleic acid sequence-
based amplification), RPA (recombinase polymerase amplification), LAMP (loop-mediated 
isothermal amplification), CPS (cross-priming amplification), HDA (helicase-dependent 
amplification), NEAR (nicking enzyme amplification reaction), etc17–21. Of these, LAMP is the 




NAAT is a tri-stage process involving sample preparation, NA amplification, and detection. 
Despite advances made in the technology, its application in diagnosing polymicrobial infectious 
diseases (multiplexing) is often only achieved with a trade-off of specificity or sensitivity. These 
challenges are mostly attendant to the two later stages, amplification and detection.  
During amplification, primers specific for the proliferation of a region in the target organism's NA 
anneal to specific regions. This process is achieved with little or no challenges when only one 
etiologic agent is of interest. Its complexity increases with an increase in the number of targets, 
and consequently, the number of primers species needed. This complexity is especially true for 
LAMP, in which 4 - 6 primers are essential for both increased specificity and speed of amplifying 
a specific target13,16,18. The assortment of the primer species in the reaction mix often increases the 





the others24,25, in most cases unsuccessful amplification due to reduced mobility/ interaction of the 
primers with their targets.    
 
The Essence of Multiplexing 
 
Multiplexing in molecular diagnostics has become increasingly important due to the need to screen 
for multiple pathogens and increase sensitivity, specificity26, and inclusivity. The ability to screen 
for numerous molecular biomarkers also increases the chance for a more precise prescription 
within the first clinic visit. Respiratory tract infections, diarrheal diseases, urinary tract infections, 
including cancers, are all conditions that could present symptoms triggered by a myriad of 
possibilities. How do you attend to these at the point of care without conducting a barrage of tests 
and screenings? Multiplexing provides a unique way of screening for multiple (molecular) 
biomarkers to offer timely interventions. 





As illustrated in Fig. 1.1 below, in spatial differentiation, pre-treated samples are distributed into 
multiple wells, each containing primers for the amplification of a specific NA target. While this 
achieves the much-needed multiplexing, it sacrifices the sensitivity of the assay, as the distribution 
further dilutes the concentration of the target nucleic acid in the sample stream. Thus, the assay 
could be reported as negative if the limit of detection of the assay is not low enough to detect low 
copy numbers of the target nucleic acid. 
 
There is also a possibility that the well will not receive any specific targets, even though it is 
present in the primary sample. This false-negative result could complicate patient conditions; 
therefore, it is most undesirable. To solve this problem, most devices (e.g., Cepheid GeneXpert, 
BioFire FilmArray) and researchers29,30 use a dual amplification (amplify-distribute-amplify 
again) process. Through this process, the first amplification step proliferates all NAs present in the 





seems to address the problem, it increases the instrument's complexity by including fluidic 
modules, valves, more reagents, longer turnaround time, etc. 
 
 
Fig. 1.1 Illustration of spatial multiplexing and its major demerits 
 
These all add to an increased cost to the consumer, thus making it unideal for use in low and 
middle-income (LMIC) or low-resource settings. The 2-stage amplification is also not ideal for 
iNAT (especially LAMP), considering the possibility of competitive amplification. The 
multiplicity of primers required to amplify all the targets may also lead to non-specific 




An alternative to the spatial technique is spectral differentiation.  Molecular events leading to the 
detection of different etiologic agents are monitored using fluorophore-labeled primers or probes 





Thus, the excitation and emission spectra of each fluorophore are used as a tracer for the 
identification of a specific target. Unfortunately, only a maximum of 4 to 6 spectral (excitation and 
emission) signaling can be achieved with minimal crosstalk (Fig.1.2). 
The spectral overlap is avoided because it leads to the generation of false signals and the loss of 
specificity (i.e., false-positive results can be produced). This makes it difficult to achieve 















Fig. 1.2 Demonstration of crosstalk among cy5 (649/670), FAM (492:518), Hex (533:559), and 
Texas Red (595:620) 
 
The challenges attendant to both techniques described above make it exceptionally difficult to 
develop assays and devices targeted at diagnosing polymicrobial infectious diseases at POC and 
limited-resource settings using nucleic acid amplification technologies such as LAMP. Thus, 
diseases such as lower respiratory and urinary tract infections are still difficult to diagnose without 
the use of culture-dependent techniques. Another major challenge, especially with LAMP, is the 
propensity for false priming31 or secondary structure formation leading to false positives. This 
impacts antibiotic stewardship and is mostly experienced during multiplexing due to the high 















Unfortunately, both methods discussed above are not ideal for higher-order multiplexing with 
LAMP, especially because the 2-stage amplification would require a combination of PCR or 
RPA32 (stage1) and LAMP (stage 2), thus defeating one of the objectives of POC diagnostics, rapid 
turnaround time. 
In improving the applicability of LAMP in higher-order multiplexing, challenges bordering on 
detection and amplification must therefore be solved. Hence, the objective of this research is to 
design and develop novel platforms that would enhance the exploitation of LAMP and other iNAT 




To achieve higher-order multiplexing (9+) without the limitations discussed above, an important 
factor in controlling was the plurality of the primers within the reaction mix. With this in mind, 
we designed some ideas: 
 
1. Diauxic-Like Batch Multiplexing 
 
We proposed controlled delivery of LAMP primers using a principle called diauxic batch 
multiplexing (DBM). In principle, DBM will solve two major problems common to multiplex 




It has been shown that it is possible to specifically amplify up to three DNA targets per reaction 
vessel using LAMP with a low risk of primer dimerization22. Consequently, we proposed the use 
of a fed-batch delivery of primers into the reaction vessel, as shown in Figure 1.3 (a-c). This way, 
only primers required for targeting three pathogens are available for amplification at any point in 
time. For example, screening for about nine DNA targets is broken into three batches with primers 
that target only three pathogens available per batch (Fig.1.3). 
 
To control the number of primer sets available for reaction, the successive batches introduce both 
their primers and the preceding batch's primer-blocking oligonucleotides. The primer-blocking 





interfering with the current batch. With each batch amplification running for about 30 or fewer 




Fig. 1.3 (a-c)  Illustration of the principle of diauxic-like batch multiplexing (DBM) 
 
Here, capitalized alphabets represent target nucleic acid, the lower-case alphabets represent 
primers (forward inner primer, backward inner primer, forward outer primer, backward outer 
primer, forward loop primer, and backward loop primer) for each corresponding target. The 
colored lines represent the three fluorophores used for the three experimental batches. Batch 1 





and F are present while E is not present; in batch 3, none of the pathogens G, H, and I are present. 
Note that the starting fluorescence threshold of each successive batch is the maximum fluorescence 




As only three pathogens are targeted per batch, only three fluorophores are used in the entire 
process. The maximum fluorescence signals from preceding batch amplification serve as the 
threshold for the next batch. This gives the fluorescence signal a unique characteristic curve, as 
shown in Figure 1.4. The curve would resemble the growth response curve of E. coli in response 
to media containing both glucose and lactose, thus giving it the name "diauxic-like." It is hoped 
that the fluorescence signals will also be used for automation for the release of primer-blockers. 
Thus, only blockers to the primers whose fluorescence signals did not increase in the preceding 
batch will be released to avoid introducing non-functional oligonucleotides, which could introduce 
non-specificity. A major assumption to the fluorescence signaling is that each preceding batch 
relative fluorescence would not saturate the photodiode's detection limit. 
 
 




While this seemed like a good idea, all experiments showed an increased difficulty of continuing 
to batch two after batch one amplifications. Among other things, it also revealed the possibility of 





with DBM experiments was the propensity for carryover contamination due to the re-opening of 
















Fig. 1.5 The addition of primer blocking oligos into the amplification mix (Blocker + standard), 
and the pre-treatment of primers with the blocker - ex situ, yields the same result as NTC. In 
comparison, amplification with the standard primers was positive. 
 
 
2. Temperature-Dependent Cascaded Lamp Multiplexing, TCLM 
 
Much like DBM, TCLM involves a programmed release of locked nucleic acids (LNAs) primers 
immobilized onto amplification vesicles.  The LNAs are programmed in such a way that their 
melting temperature, Tm, corresponds to the batch amplification temperature. For example, the 
release of batch 1 primers could be designed to occur at a temperature of 60oC which would also 
be the amplification temperature for batch 1. Batch 2 can be programmed to occur at a higher 





primers from a previous batch would not interfere with the next. This presents an advantage over 




Fig. 1.6 Illustration of 6-plex TCLM 
 
 
A modified version of the TCLM involves the encapsulation of batch primers in wax (aliphatic 
hydrocarbons) which can also be programmed to become Tm-dependent. 
 
3. Primer Payload Platform, P3 
 
As a third alternative, we explored the use of the primer payload platform which involves the 
adoption of three major technologies: 





• Digital Droplet Loop-mediated Isothermal Amplification (ddLAMP)  
• Bead Encapsulation 
 
 
As summarized in Fig.1.7, these three methodologies are combined to become a primer-payload 
system for the delivery of target-specific primers and NA targets into defined picoliter-scale 
reaction vesicles. Shown in Fig. 1.8 are preliminary designs of the device and microfluidic 


















































Bead-Based Spectral Sharing 
 
Stefan Rödiger et al.33 showed the possibility of differentiating bead populations based on the ratio 
of the gray values of the infused fluorescent dyes. In combination with the diameter of the beads, 
it is possible to derive several population clusters or signatures, Fig 1.7.  
 
 
Fig. 1.9 Bivariate plot of PopId by bead diameter showing population clusters. 
 
 
As shown in Fig.1.9, by employing only two fluorophores, rhodamine and coumarine, infused in 
polymethylmetacrylate (PMMA) beads of two different diameters, it is possible to differentiate 12 
bead clusters. By mapping each cluster as a signature to a particular molecular target, higher order 
multiplexing (12) can be achieved without the challenges of spectral crosstalk. This method is 





In comparison to bulk nucleic acid amplification methods, droplet digital (isothermal) nucleic acid 
amplification, dd(i)NAT, allows for single NA detection in a sample stream. This is achieved by 





hydrophobic interfaces. Apart from the increased sensitivity which this method offers, it provides 
a method for the quantification of target DNA concentration in the bulk sample (equation 1) 
without the need for a standard curve. 






                         equation 1   
Where 𝑁𝑛𝑒𝑔  = 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑑𝑟𝑜𝑝𝑙𝑒𝑡𝑠, 𝑁 = 𝑡𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑟𝑜𝑝𝑙𝑒𝑡𝑠, 𝑉𝑑𝑟𝑜𝑝𝑙𝑒𝑡 =





By encapsulating microparticles in distinct reaction vesicles, researchers have been able to analyze 
single cells34, apply LAMP35 in pathogen detection, as well as perform single cell barcoding and 
sequencing36. All these rely on the ideology of increased sensitivity and specificity, as well as high 
throughput performance. 
By employing this technology, we will be creating a system for high throughput screening, 
decreased time to positive results, increased statistical relevance of our results, increased 
















Scope of Thesis 
 
The scope of this thesis is to develop the above-mentioned unit systems which will enable the 
development of the primer payload platform. By combining these technologies, we would create 
a system for conveying LAMP primers and their specific targets into distinct reaction vesicles for 
amplification. As such, my thesis is geared at answering the following questions: 
1. Can we successfully functionalize the bead surfaces with the primers? 
2. What mechanism can we use to ensure the primers are available in solution when needed? 
3. Can the surface-bound primers successfully hybridize target DNA? 
4. Can we successfully create a microfluidic chip for bead encapsulation and ddLAMP? 
5. How do we encapsulate only 1 bead per droplet without the use of very expensive tools? 
 
Chapters 2 and 3 will address assay-based questions (1-3) above while chapters 4 and 5 will 
address the questions bordering on microfluidic devices, ddLAMP and bead encapsulation 
methods. 
It is worth mentioning that in the course of this research, many interns and graduate students joined 
the team and collaborated in various scales. My contribution to the work presented in each chapter 


















TABLE 1 My contributions throughout this thesis project 
 
Chapter Collaborators My Contributions 
1: Initial 
Prototypes N/A 
Idealized and designed original microfluidic cartridge and device 
prototypes 












Performed functionalization of carboxyl-beads with streptavidin and 
biotinylated probes 
Designed functional LAMP primers and probes with different labels 
and functionalities used in the assay 
Developed methods for imaging beads using the confocal microscope 
Established methods for analyzing fluorescence micrographs using 
ImageJ, and python 
Designed FRET analytical methods for determining the efficiency of 
indirect primer carrying efficiency of the probes 
Created and validated the direct method of primer delivery 
Idealized and modified chimeric primers used in the direct coupling 
method 
Created assay recipe and optimized protocols for simultaneous in situ 








Designed experiments to determine bead-primer carrying capacity 
Developed method for testing for primer-DNA complexing 
Modelled bead-primer carrying capacity using bead metadata and 
manufacturer's certificate of analysis 







Developed a co-flow microfluidic droplet generation system 
Conceptualized, designed, fabricated and optimized prototypes of 
microfluidic cartridges using 3d printing, soft lithography, laser 
cutting, and resin casting 
Validated methods for the generation of highly monodisperse picoliter-
scale droplet 
Developed methods for and analyzed droplet micrographs using 
ImageJ, Excel, Python, APEER, MIPAR, JMP, etc. 
Established SOPs for the fabrication of microfluidic cartridges, and 
troubleshooting of pumping systems 
Optimized droplet generation chemistry for droplet mechanical and 
thermal stability 
Designed, fabricated, and optimized prototypes for dense bead 
resuspension and mixing 
5. Others N/A 
Microbiology: developed media such as MRS broth for L. acidophilus 
culturing, performed BSL-2 bacterial culturing, DNA extraction for 
PCR and LAMP amplification 
NA Amplification: conducted experiments on colorimetric LAMP, 
droplet digital LAMP, designed primers and primer-quenchers, 
performed troubleshooting on LAMP protocols, designed LNA oligos, 





Chapter 2: Bead Functionalization with Target-specific Primers 
 
 
The success of our platform largely depends on the efficiency of binding primers onto the beads 
and the feasibility of primer-DNA hybridization upon mixing with the sample stream. 
Functionalization of the beads (polyAn GmbH) with primers is preceded by the coating of the 
beads with either streptavidin (when purchased beads are not streptavidin-positive) or 
hybridization probes directly. The former is widely achieved via 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) cross-linking37 (figure 2.1a) while the later can be 
achieved through azide-alkyne cycloaddition (Click-chemistry)38,39 (Fig2.1b) or streptavidin-












Fig. 2.1 Illustration Of EDC Chemistry (A)37 And Click Chemistry (B)43 
 
Considering that the probes are covalently bound to the bead surface, click chemistry would be 





achieved using streptavidin-biotin coupling. Ideally, we need to maximize the primer-carrying 
capacity of the beads, hence the choice. 
 
Functionalization of Beads With Streptavidin 
 
PMMA microbead suspension (PolyAn GmbH, 3D-carboxy functionalized beads) is centrifuged 
at 10,000 RPM for 60 secs to remove the supernatant. The pelletized beads are washed using 200 
µL of 0.1 M 2-(N-Morpholino)-ethanesulfonic acid buffer (MES pH 4.5, Sigma Aldrich) with 
vortexing. On demand, 25mg EDC / mL MES buffer is reconstituted and mixed with the beads at 
1200 RPM, 28oC for 30 minutes in Multitherm incubator (Benchmark Scientific, USA). After 
incubation, the suspension is centrifuged at 10,000 RPM for 60 seconds and the supernatant is 
removed. The pellets are washed with 200 µL of 0.05x phosphate-buffered saline, PBS, pH – 7.4 
(Gibco) without vortexing. The washed beads are then mixed with 120 µg streptavidin 
(Invitrogen)/ mL of PBS and incubated at 28oC for 4 hours at 1200 RPM. After incubation, the 
bead suspension is centrifuged at 10,000 RPM for 60 secs and washed 3 times with 200 µL TBST- 
buffer (50 mM Tris, 154 mM NaCl, 0.01% Tween-20, pH 7.4) without vortexing and resuspended 
in 200 µL TBST. 
 
 
Fig. 2.2. Confocal micrograph of transparent PMMA beads showing ligand fluorescence from 








Functionalization of Streptavidin-Positive Beads With Biotinylated Oligos 
 
Oligos with a stock concentration of 100 µM biotinylated probes and primers, and biotin and 
fluorophore-labeled oligos were synthesized by IDT, USA – Table 2. 100 µL of the streptavidin-
positive beads is mixed with 25 µL oligo (100 nM stock) and 15 µL TBST-buffer. The suspension 
is incubated at room temperature for 1 hour with vigorous shaking at 1200 RPM. After incubation, 
the supernatant is removed by centrifuging at 10, 000 RPM for 60 secs. The beads are then washed 
3 times with 200 µL TBST without vortexing.  
 
Table 2: Modified oligos used for the functionalization of streptavidin-positive beads 
 
Green =main sequence, Red = fluorophores, Black = biotin, Purple = RNA moiety,  
Orange = elongation sequence 
Successful functionalization of the beads is assessed by fluorescence microscopy as shown in Fig. 
2.2. 
 
Indirect Bead Functionalization with Target-Specific Primers 
 
It is worthy of note that the images shown in Fig 2.2 are streptavidin-positive beads functionalized 
with biotin and fluorophore-labeled hybridization probes (Ecoli_Cap_F_Bio). A very critical 
question after this step, therefore, was to determine the efficiency of hybridizing actual primers to 
the probes as well as its merits and demerits. This method was dubbed indirect functionalization 
method owing to the fact that the primers are not directly coupled onto the streptavidin-positive 
beads. 
To achieve this, Escherichia coli forward inner primers (FIP) were modified on the 5' end by 
attaching a complementary sequence to the probe and labelled with a quencher. 
Primer Sequence (5' -3')
Ecoli_Cap_F_Bio /5ATTO633N/TAGTACCGGTACAATATATAT/3Bio/
Ecoli_FIP_DZ2 ACC GGT ACT ACG GTT CGG TCC TCC AGT TAG TGT TTT CCC GAA ACC CGG TGA TCT







Fig. 2.3 Illustration of indirect primer coupling method and sensing using FRET. 
 
 
Ideally, this method is preferred because it would save the cost of having a unique hybridization 
probe per primer. It would also simplify the process of functionalization as it would be difficult to 
control the ratio of FIP and BIP probe: F3 and B3 probe: LF and LB probes to be taken up by the 
beads for successful LAMP amplification. 
We assessed this method for primer-carrying efficiency using fluorescence resonance energy 
transfer (FRET). In the protocol, biotin and fluorophore-labeled probes were used to functionalize 
transparent PMMA beads following protocols discussed in the section above with 52.5 µL of bead 
stock suspension. After functionalization, the suspension was divided into two ("Control" and 
"FRET"). Aliquot of Ecoli_FIP_DZ_Q (quencher-labeled FIP) was added to the "FRET" batch to 
make up 10 µM. The mixture was incubated at 28oC for 2 hours at 1200 RPM. After the 
hybridization protocol, the beads were washed 5 times with TBST without vortexing and imaged 
using confocal microscopy (Leica SP5) (Fig2.4A, B). Ligand fluorescence signals from the images 









Fig. 2.4 Bead functionalization using Method 1: Fluorescence images (A- control), (B- FRET) 
and bar plots comparing the fluorescence signals from the control and FRET experiments 
 
These showed incomplete FRET signifying inefficient hybridization of the primers to the probes. 
In fact, a comparison of the RFU between the control and the experiment (FRET) batches showed 
only 34.5 % loss in fluorescence due to quenching. This may have been as a result of steric 
hinderance, rigorous wash step or inefficient hybridization protocol. However, an attempt at 
optimizing the protocol by heating the mix to 70oC for 30 minutes at 1200 RPM and holding it at 
room temperature for 2 hours at 1200 RPM yielded lower FRET efficiency with a 29.5% loss in 




Fig 2.5 Bead functionalization using Method 2: Fluorescence images (A- control), (B- FRET) 






This decline in FRET efficiency using the second protocol may have been as a result of increased 
steric hinderance due to bead shrinkage at higher temperatures (Figure not included). It has been 
shown that upon conditioning (subjecting the beads to high temperatures), the beads shrink, thus 
compacting the density of the probes per the new surface area. Additionally, Holmberg et al. 
showed that Streptavidin-biotin interactions can be reversibly broken by heating them to 70oC in 
water44, thus partly suggesting a reason for the lower ligand fluorescence seen in Fig. 2.4 compared 
to Fig. 2.5. 
These may be reasons why hybridization of the primer may be more favorable at lower 
temperatures and should be optimized with that in mind. Conclusively, we realized that while 
indirect primer-bead coupling may be the best for thermal release into the reaction mix, it cannot 
be exploited in delivering maximum primers to the sample. 
The inefficiency of this method for our systems was further supported by the effect of the modified 
primers on LAMP amplification. 
 
Effect of Modified Primers on LAMP 
 
Variants of the modified primers (without quencher and fluorophore) (Table 2) were used to 
determine the feasibility of NA amplification with the modified primers. The figure below (Fig. 
2.6) shows that compared to the unmodified primers (standard), the modified primers (6DZ) could 
not be successfully used for amplification. The exact reason behind the failed amplifications with 
the DZ primers is unclear, however, a couple of factors such as change in the thermodynamic 
properties of the primers, and secondary structure formation, were suggested as possible reasons. 










Fig. 2.6 E. coli DNA LAMP to determine the feasibility of NA amplification with the modified 




Direct Primer Coupling Method 
 
We showed previously that modification of primers by attaching an extra sequence interferes with 
their functionality and that the use of the indirect primer-coupling method was largely inefficient. 
Therefore, we considered the possibility of direct functionalization of the beads with primers. 3 
major considerations of the new method are: 
• Increased efficiency in coupling the primers onto the beads, 
• Ease of releasing the primers on demand, and 









Primer Target Organism Sequence (5' - 3')
Ecoli_FOP_RDZ E. coli rUrGrU rArCrC rGrGrU rArCrU rArUrU GGC GTT AAG TTG CAG GGT AT
Ecoli_BOP_RDZ E. coli rUrGrU rArCrC rGrGrU rArCrU rArUrU TCA CGA GGC GCT ACC TAA
Ecoli_LoopF_RDZ E. coli rUrGrU rArCrC rGrGrU rArCrU rArUrU ACC TTC AAC CTG CCC ATG
Ecoli_LoopB_RDZ E. coli rUrGrU rArCrC rGrGrU rArCrU rArUrU GTG AAA GGC CAA TCA AAC C
Ecoli_FIP_RDZ E. coli rUrGrU rArCrC rGrGrU rArCrU rArUrU CGG TTC GGT CCT CCA GTT AGT GTT TTC CCG AAA CCC GGT GAT CT
Ecoli_BIP_RDZ E. coli rUrGrU rArCrC rGrGrU rArCrU rArUrU TAG CGG ATG ACT TGT GGC TGG TTT TTC GGG GAG AAC CAG CTA TC
F_Ec_FIP_RDZ_Bio E. coli /5ATTO633N/rCrCrU rGrGrU rCCG GTT CGG TCC TCC AGT TAG TGT TTT CCC GAA ACC CGG TGA TCT rCrUrC rUrCrU rCrU/3Bio/
F_Ec_FIP_RDZ E. coli /5ATTO633N/rCrCrU rGrGrU rCCG GTT CGG TCC TCC AGT TAG TGT TTT CCC GAA ACC CGG TGA TCT rCrUrC rUrCrU rCrU
20190829_F_Ec_RDZ_Bio E. coli /5ATTO633N/CGG TTC GGT CCT CCA GTT AGT GTT TTC CCG AAA CCC GGT GAT CTrC rUrCrU rCrUrC rU/3Bio/
 
 
Fig 2.7 Direct coupling of primers to streptavidin-positive beads and release mechanism 
 
In designing a method for the direct functionalization of the beads with choice primers, there are 
only 2 options; directly modifying the 5' end of the primers with biotin or attaching a biotinylated 
sequence that can be cleaved easily to release the active primers. A limitation of the first option 
was that it required breakage of the biotin-streptavidin interaction, which, although can be 
achieved by heating the amplification mix to at least 70 oC44, the optimal temperature for our assays 
was at 68oC. Also there is no guarantee that all biotinylated primers would be released. 
To determine the feasibility of option 2, we redesigned the E. coli primers to become chimeric 
(Table 3), having sequences which could be easily cleaved by RNase enzyme as shown in Fig. 2.7 
 












Chimerism For Primer Delivery 
 
To assess the feasibility of primer release using the chimeric primers, 46 µL of KOM1 (transparent 
streptavidin-positive) beads (PolyAn) was centrifuged at 10,000 RPM for 60 seconds to remove 
the suspending stock fluid. Into the bead pellets, 0.8 µL of 100 µM chimeric primer 
(20190829_F_Ec_RDZ_Bio) from IDT was added and the volume was made up to 50 µL using 
TBST. The mixture was incubated for 4 hours at 25oC before being washed 3 times using TBST. 
After the wash step, the bead was resuspended in 50 µL TBST and 10 µL aliquot was removed for 
pre-amplification microscopy (Fig 2.8a). The remaining bead suspension was centrifuged and 
drained of the supernatant for use in LAMP.  
To enhance digestion of the RNA moiety, the LAMP master mix for the bead-based LAMP 
contained 300 mM NaCl, 1x TE buffer (Usb - 10mM Tris + 1mM EDTA, pH 7.4) and 2% v/v 
5000 U/ mL Rnase A/T1 (ThermoFisher), FIP-carrying beads, and All-but-FIP(ABF) primer mix 
(1.6 µM BIP, 0.2 µM each of F3 and B3, 0.4 µM each of LF and LB). Two controls were set up 
alongside this experiment, with one containing standard LAMP mix and reagents and the other 
containing unbound chimeric FIP, ABF, and equal concentrations of TE, NaCl, and RAT1-E as 
the bead-based LAMP. The LAMP setup was incubated at 68oC using Light Cycler 96 (Roche) for 
1 hour. 
As shown below, of the three experiments, only the bead-based LAMP did not amplify 
successfully. Interestingly, however, post-amplification microscopic analysis of the functionalized 
beads showed successful digestion of the RNA moiety signified by the absence of ligand 










Fig 2.8. Use of chimeric primers as a primer delivery system. A. Pre-amplification fluorescence 
imaging of the beads functionalized with chimeric primers. B. Post-amplification fluorescence 
imaging of the beads from the bead-based LAMP C. Amplification of E. coli DNA using normal 
primers, ex-situ digested chimeric FIP (mFIP) + ABF, and Bead-delivered FIP (BLAMP). 
 
 
Although the bulk amplification experiment failed, the results showed that digestion of the RNA 







Optimization of In-situ RNA Digestion and Simultaneous Amplification 
 
Further experiments showed that the addition of TE and NaCl are implicated in the inhibition of 
LAMP (Fig. 2.9 A). Hence, we optimized the primer release system using non-fluorophore-labeled 
and non-biotin-labeled chimeric primers. The protocol was optimized such that digestion would 





















Fig 2.9 Amplification of E. coli DNA using chimeric primers and standard primers. A: titration of 
different percentages of recommended RAT1-E digestion excipients. Full Option refers to 300mM 
NaCl + 1x TE (10mM Tris + 1mM EDTA, pH 7.4) B: Optimization of in-situ chimeric primer 






In developing the protocol, all 6 LAMP primers for E. coli amplification were chimeric. During 
this assay design, we learned that unlike primers modified using a DNA sequence, the chimeric 
primers were able to amplify target DNA albeit slower (Fig. 2.9 A: Chimeric – Nil DNA) and the 
addition of more than 2% RAT1-E inhibited the amplification (Fig 2.9 B: Chimeric + 4% RAT1-
E DNA). In the end, all that was needed for successful chimeric primer digestion and DNA 
amplification using the 6 chimeric primers was the addition of 2% v/v RAT1-E into the master 
mix. 
 
Unfortunately, the optimization of the chimeric primer digestion (primer release mechanism) for 
integration into LAMP did not lead to successful bulk LAMP amplification using bead-delivered 
FIP primers. A major re-occurrence, however, was a decrease in the time to positive reaction of 
the chimeric system compared to the normal primers. This raises the question, is it possible we 
made LAMP more sensitive? Also, what was directly responsible for the phenomenon, 2% RAT1-




We successfully developed a system for the functionalization of the microbeads with streptavidin 
and primers using EDC chemistry and streptavidin-biotin interactions respectively. We also 
developed a mechanism that could ensure the on-demand release of primers by exploiting RNA 
chemistry.  
Considering the failure of bulk bead-based amplification using the developed systems, a critical 
question therefore comes up; are the beads capable of delivering enough primers for successful 
amplification? In addition to this question, there is the need to determine the feasibility of bead-
primer-DNA complexing – a critical step that would ensure that primers hybridize to their specific 












Chapter 3: Primer-DNA Complexing and Bead Primer-Carrying 
Capacity 
 
Bead-Primer Carrying Capacity, BPCC 
 
The bead primer-carrying capacity (BPCC) is very critical in determining the final volume of the 
reaction mix. Optimal reaction conditions of LAMP require a final primer concentration of 4.4 
µM, since we intend using beads with an average diameter of 20 µm, it is important that the beads 
are able to deliver enough primers to droplets with a minimum diameter of 30 µm (~14 pL).  
Considering that streptavidin is a tetramer, in determining the BPCC, we estimated for both the 
best- and worst-case scenario. The best-case scenario being that each molecule of streptavidin is 
able to couple 4 molecules of biotin, while the worst-case scenario represents a condition in which 
each streptavidin molecule is only able to couple 1 biotinylated primer. This calculation, however, 
is only feasible if the streptavidin loading of the beads are known, this is readily obtained from 
PolyAn GmbH for streptavidin-positive beads.  Although this can be determined for beads which 
were functionalized in-house with streptavidin using similar methods as that of Dorgan et al40, we 
did not pursue it. For the purpose of experimentation, we assumed similar capacity/ efficiency as 
that reported by PolyAn. 
In determining the volume of droplet required for the BPCC to equal optimal primer concentration, 






















Using the above table, we determined that at 25% efficiency (worst-case scenario), each 21.5 µm 
bead is capable of delivering 6.45E-07 nmol oligo per reaction (6.45E-05 µM per 10 µl LAMP 
reaction). Thus, to deliver 4.4 µM of primers per 10 µL of LAMP reaction, we would require 
~68,217 beads with an average diameter of 21.5 µm. This amounts to ~106 µL of the bead stock 
(1.5 mL) for 3 replicates of the bulk amplification. As a surrogate to determine the accuracy of the 
estimates, we developed protocols for bulk NA amplification using bead-delivered primers using 
both indirect and direct methods. 
 
In a protocol involving indirect primer-coupling onto beads, we functionalized 129 µL of 21.5 µm 
streptavidin-positive beads with RDZ primers and probes. Equimolar concentrations (10 µM) RDZ 
primers and Ecoli_Cap_F_Bio probes were incubated by heating to 95oC at 1200 RPM. This 
allows for the hybridization of the primers to the probes. The probe-primer mix is then used to 
functionalize the beads at room temperature for 2 hours at 1200 RPM.  After incubation, the 
mixture was stored in ice prior to use in amplification. Understandably, bead-based amplification 
using this protocol failed (Fig. 3.1) due to inefficient primer delivery by the beads using the indirect 
primer hybridization method as shown earlier via incomplete FRET. 
TP190214KOM1 SA Loading 10.5 nanomol/g beads
E F
1 Bead Density 1.18 g/cm³
2 Mean Bead Diameter 21.5 µm
3 ∏ 3.141592654 PI()
4 Bead volume 5203.720981 µm³ (4/3)*F3*(F2/2)^3 or 3.823e-9 cm3
5 5.20372E-06 µL F4*1e-9
6 5.20372E-08 cm³
7 Mass Per Bead 6.14039E-08 g
8 Number of beads per gram 16285608.51 beads
9 SA Loading Per Bead 6.44741E-07 nanomol SA per bead
10 # of beads per 10uL of stock 19217.01804 Beads/10uL of stock.
11
12 Vol. per vial 1.5 mL
13 % Solid (KOM1) 1%
14
15 Actual Vol of Beads in Vial 15 µL F12*F13*1000
16 # Beads per vial 2.88E+06 Beads F15/F5
17 Beads per 10 µL  @1% solid 19217.01804 Beads/ 10 µL (10/F5)*F13
18
19 Biotin/ Oligo per Bead 2.57896E-06 nanomol oligo/ bead Considering 100% efficiency MAX oligo carrying capacity per Bead
20 Biotin/ Oligo per Bead 6.44741E-07 nanomol oligo/ bead Considering 25% efficiency Min oligo carrying capacity per Bead
21 For beads in 10uL Stock 0.04956 Nanomol oligo Considering 100% efficiency MAX oligo carrying Capacity/ 10 uL stock









Using the direct method, 58.76 µL of streptavidin-positive beads (21.5µm) was functionalized 
with F_Ec_FIP_RDZ_Bio (biotinylated E. coli FIP primer). These were considered enough to 
deliver 1.6 µM FIP primers into the reaction mix. A final concentration of 1.6 µM of FIP was used 
to functionalize the beads at room temperature and 1200 RPM. After functionalization, the beads 
were washed and resuspended in nuclease-free water to remove aliquots for microscopy (before 
amplification). The bead suspension was then centrifuged at 10,000 RPM and 19.26 µL of the 
supernatant was removed, leaving behind 20.8 µL. The remaining volume was used to resuspend 
the beads, distribute the beads into 2 empty wells (10.4 µL each) prior to reducing their volumes 
0.74 µL after centrifugation. Other reagents, including ABF (all-but-FIP) primers were added 
exogenously. This assay also failed and could be due to inaccurate estimation of the carrying 
capacity of the beads which would result to the delivery of suboptimal FIP primer concentration 
in the reaction mix. 
 
 
Fig. 3.1 Amplification using bead-bound FIP (direct, indirect), biotinylated chimeric FIP primers 
(mFIP) and standard primers (Normal).  
 
Experimental Determination of BPCC 
 
In this experiment, 16 µL (~19,200 beads) of KOM1 beads was functionalized using biotin and 





functionalization were applied, after which confocal microscopy was used to capture the bead 
ligand fluorescence. A pictorial map of the steps used in analyzing the beads for fluorescence is 




































The results of the experiment (Fig. 3.3) showed that the beads were saturated at 0.1 µM probe 
loading. Thus, implying that ~19000 beads are only capable of delivering 1E-6 µmoles of primers 
in a 10 uL LAMP reaction. In order to deliver 1.6 µM FIP concentration required for bulk LAMP, 
we would require ~304,000 beads (125 uL of the KOM 1 stock). Given that the volume of each 
bead is 4.19E-6 µL, at 74% packing efficiency, the beads alone would take up ~26 % of the 10 µL 
reaction volume space. This may not really be a problem but have not been tested. A major 
consideration is that we would need 5 folds more stock bead volume than what we used in previous 









We considered the possibility of improving the BPCC beyond what is obtainable traditionally with 
the beads. Two possibilities were opted for; 1. Using dendrimers to ensure multiplicity of the 
primer density around each bead; and the use of primer hinging oligos, PHO. 
The PHO is by design, short RNA moieties capable of linking the 5' and the 3' ends of 2 different 
primers together (as shown in Fig. 3.4A). As shown in Fig 3.4B, we could not determine the 
success of the procedure from gel electrophoresis. This could be as a result of degradation of the 














Fig. 3.4. A: Illustration of the Dendrimeric (left) and PHO Systems (Right) B: Gel 













A major unit process in our platform is designed to exploit primer-DNA hybridization chemistry 
such that bead-bound FIP primers would anneal to their specific genomic DNA targets. 
As illustrated in Fig. 3.5, to assess the feasibility of this, a 100 DNA copies/ µL dilution of E. coli 
genomic DNA was made and divided into 2 vials (S1 and S2). 50 µL of S1 was added to pellets 
of PolyAn KOM1 beads (~1.92E+04, 20 µm beads) functionalized with biotinylated E. coli FIP 
chimeric primers (F_Ec_FIP_RDZ_Bio) using the direct method. The mixture was heated to 95oC 
for 1 minute, then held at 15oC for 30 minutes using the Multitherm instrument. After incubation, 
the tube is allowed to sit for 3 minutes to allow the beads to settle. Albeit without beads, S2 was 
put through the same processes as S1 in order to ensure that any differences between S1 and S2 
were as a result of primer-DNA coupling. 
Supernatant from S1 was used to prepare PCR mix at a final concentration of 10 copies/ µL 
(assuming the DNA concentration in the suspension is not reduced via bead-primer-DNA 
coupling).  The same was done for S2. The result of the PCR from both S1 and S2 are shown 
below (Fig. 3.6) with a Cq difference of 4.06 minutes translating to the uptake of 450 copies of 
DNA out of 500 in S1. 
 
 







A similar process was carried out using ~35.9E+06, 2.2 µm beads, however, the starting 
concentration of S1 and S2 is 1.94E+4 copies/ µL (nanoquant determination) E. coli gDNA. From 
S2 dilutions up to 970.5 copies/ µL E. coli gDNA were made and amplified alongside the test. The 
qPCR test results show a delayed amplification of the test experiment (with beads) by ~1.5 minutes 
compared to the starting concentration of S2 (Fig. 3.6B). From standard curve calculations, this 
translates to a ~23% reduction in the DNA concentration showing an uptake of 256 copies of DNA. 
Both experiments present a successful proof of the concept of using the bead-bound FIP primers 
to capture specific genomic DNA from a sample stream.  
 












                equation 2 














Fig. 3.6 Experiments to determine if FIP-bound primers are capable of carrying target DNA.  A: 20 µm beads were used with a starting 
concentration of 10 copies/ µL. B. Repeat of the FIP-DNA hybridization experiment using 2.2 µm beads and a starting concentration of 
2.94E+04 copies/ µL (inset: melt curve justifying that NTC fluorescence signals are due to secondary structure from LAMP's FIP used 






Conclusion and Next Step 
 
Experimental BPCC showed revealed that a very large number of beads are needed to achieve bulk 
amplifications using bead-borne FIP, and much more for the rest of the primers. Considering the 
cost implication of this, it would be worthwhile to switch to droplet-based testing regimes.  
 
Using the same theoretical BPCC estimation from previous experiments, we determined that the 
minimum volume of droplets required to equate the BPCC to 4.4 µm of primers in a droplet is 
~150 pL. This requirement necessitated the development of protocols for the generation of 
picoliter-scale droplets. It is worthy of note that these estimations were not made using the 
theoretical methods ignoring the experimentally derived values. Rather, both the theoretical 
BPCC-based experiments and the microfluidics methods discussed in Chapter 4 happened within 
the same time frame. The developed methods can also be adapted to the experimentally derived 



















Chapter 4: Microfluidics and Droplet Generation 
 
Why Embrace Microfluidics 
 
Cheng et al46 showed the possibility of LAMP using bead-bound FIP in droplets generated via 
high frequency emulsion generation. While their methods seem to predicate ours, they failed in 
optimizing the efficiency of bead encapsulation. Thus, out of 8.4E+06 beads, only about 12% had 
single beads. Their method was also limited by the random distribution of the exogenous primers. 
These may have led to their report of only ~10% of single bead-containing droplets being positive 
for amplification. More so, such bead encapsulation methods are not ideal for multiplexing and 
leads to excessive loss of beads, primers, and reaction efficiency. 
To achieve better results, we needed to make concerted efforts to ensure more efficiency in the 
encapsulation of the beads hence the need for the development of microfluidic platforms as 
discussed in this chapter.  
 
Microfluidic Device Fabrication 
 
To the best of our knowledge, the generation of highly monodisperse picoliter-scale droplets have 
been mostly linked to the use of very elaborate and expensive methods. For example, many 
researchers47–56 have generated picoliter and femtoliter-scale droplets using devices fabricated 
with techniques such as photolithography,  micromachining, laser, and wet etching, 
pyroelectrodynamism57, inkjet printing58, etc. 
We required an easy, rapid method for developing microfluidic prototype cartridges which could 
serve as an alternative to photolithography. Zhang et al.59 reported the possibility of generating 50 
µm droplets using 3d printed cartridges. Other researchers59–63 have also shown the application of 
3d printing for the generation of droplets but not in the scale reported by Zhang et al. To the best 
of our knowledge, Zhang's report is debatable as they were only able to achieve a minimum Ddrop 
~0.6 using Dtubing of 177 µm (Ddrop = Ddiameter/Dtubing). This places their smallest droplet diameter 
at ~106 µm. More so, in order to achieve this, a very low ratio of the volumetric flow rates of the 
dispersed phase to the continuous phase (Qd/ Qc << 0.015) was employed, a major cause of 
excessive waste of the continuous phase medium. Thus, while the use of 3d printing has been well 
reported for droplet microfluidics, proof of the generation of highly monodisperse picoliter-scale 






We investigated dropwise and co-flow regime for droplet generation, as expected, these yielded 
droplets which were much larger than we desired (Fig. 4.1A). Other methods such as 3D printing 
- using stereolithography (SLA) and fused filament fabrication, and bonded laser cut acrylic 
materials were assessed. SLA printing of master molds61 showed the most promise with respect to 
simplicity, turnaround time, and ease of replication. 
To exploit this, 3D models of the master molds were designed using Solidworks CAD software 
(Dassault Systems) to have flow channel dimensions of 100 µm x 100 µm and inlet/ outlet ports 
of 750 µm (Fig 4.1B). Subsequently, the stereolithography files were prepared for 3D printing by 
orienting them at an angle of 45o, avoiding overhangs, using Form Labs' Preform software. The 
models were then printed using Form3 SLA 3D printer (Form Labs) on clear resin (v4 -
FLGPCL04) at a layer thickness of 25µm. The printed master molds were thoroughly cleaned with 
isopropyl alcohol to remove excess resin, UV-cured for 30 minutes, and each filled with 3g of pre-
degassed mixture of polydimethyl siloxane, PDMS – SYLGARD silicone elastomer 184 and 
SYLGARD silicone elastomer 184 curing agent (Dow Corning) combined at 10:1 w/w ratio 
respectively. The setup was degassed again in Cole Parmer Diblock oven and cured at 65oC for 45 
minutes. Once cured, the PDMS was gently peeled from the master mold and bonded onto 
microscope slides after surface activation using flame treatment as an alternative to oxygen plasma 
bonding64 and placed in 85oC oven overnight to allow the PDMS to harden.  
After fabrication, the cartridges are examined for binding strength of the PDMS by gently prying 
at them and also checked for channel dimensions under the microscope. A ± 10% tolerance is 









































Fig. 4.1 B. Fabrication of PDMS-based microfluidic Chips using 3D printed molds 
 
Pitfalls Of 3D Fabrication of Microfluidic Cartridges 
 
While making microfluidic cartridges using 3D printing, we identified several unpublished pitfalls 




One of the major challenges attendant to using 3D printing for microfluidics is the limitation of 
the printer's resolution. We find that despite the advancements in 3D printing, especially desktop 
SLA printers, it is incredibly difficult to print channels with width less than 50 µm. More so, 
printing of master molds at higher resolutions (e.g. 25 µm layer height) forces the printer to run 
for prolonged hours, thus, giving room for misaligned prints. This misalignment creates micro 
channels in the molded PDMS thereby causing leakage in the final cartridge. 
As experienced with the Form 2 and Form 3 (Form Labs) 3D printer, orientation of the 3D models 
also determines if the base of the molds would have crosshatches or a smooth finish. This is evident 





Another major consequence of the printer limitations is the difficulty in printing well-defined 90o 
edges. This impacts flow focusing more as there is always a characteristic curvature at the flow 
junction. This curvature slightly alters the principal flow focusing pattern seen on 
photolithography-based flow focusing systems. Although this principle has not been further 




As shown in Fig 4.2a, Batch-to-batch variations in channel dimensions is a major limitation of this 
system. This often comes from the post-print cleaning of master molds. Inadequately cleaned edges 
(especially around the flow channels) and other dead spaces) may lead to increased channel 
dimensions once the left-over SLA printer resin cures. More so, if the base of the mold is not 
stripped of the residual resin, it causes the base to be irregular and once imprinted onto the PDMS, 
prevents it from binding strongly onto the glass slides. This gives the PDMS a frosty appearance 
as shown in Fig. 4.2b. 
It is common occurrence for PDMS to be trapped in the vertices of the printed mold. If the cured 
PDMS is not peeled gently from the mold, there is always a risk of losing the channel wall 
definitions, which, in turn would affect the channel dimensions. More so, the idea behind the use 
of a 3D printed mold is to encourage usability of the molds. However, with the gradual and 
continuous deposition of tiny chips of PDMS, the channel dimensions continuously increase with 
continued use. In addition to these, if the PDMS is not completely cured, attempts to peel it off the 
mold creates irregularities in the channel dimension and definition. In most cases, the channel may 








Fig. 4.2 A. Batch to Batch Variations in Channel Dimensions B. Other results of procedural 
pitfalls 
 
Picoliter-Scale Droplet Generation 
 
Droplets were generated using the optimized flow-focusing microfluidic cartridges fabricated 
using 3d-printed molds and soft lithography. The continuous phase consisting of mineral oil 
(Sigma Aldrich -M3516-1L), 0.1 wt% Triton X-100 (Fisher Biotech), and 3 wt% ABIL EM 90 
(Evonik, Germany) was pumped at different flow rates, Qo = [20, 25, 50, 75, 100] µL/min. Both 
the dispersed and continuous phases were infused using two syringe pumps (KD Scientific). The 
cartridge was set on an optical microscope (Omax) for event monitoring by recording mid-
highspeed (960 fps) videos of droplet generation using Samsung Galaxy Note 10. The videos were 
used to study fluidic behaviors and other events while the droplets are collected for imaging.  
Micrograph images of the droplets were taken using confocal microscopy (Leica SP5) and their 





manually by calculating their spherical volumes. To ensure consistency and reproducibility of the 
droplet generation system, the droplet generation and analysis experiments were replicated at 




Fig 4.3 A. Left: Figure showing response of the droplet diameter to change in the volumetric flow 
rate of the continuous phase (oil). For these experiments, the volumetric flow rate of the dispersed 
phase (water) was kept constant at 1 µL/ minute. Middle: Micrograph of the droplets obtained 
during the experiment Right: Droplet diameter distribution per flow condition. This also shows the 
polydispersity index of the droplets (CV) values. B Top: Visualization of Droplet diameter: 









Droplet-Based Loop-Mediated Isothermal Amplification for DNA Amplification 
Using the Fabricated Cartridge 
 
To verify the usability of the developed cartridges in molecular applications, digital loop-mediated 
isothermal amplification, LAMP, for the detection of Lactobacillus acidophilus was performed. L. 
acidophilus obtained from MicroKwik vials (Carolina.com) was cultured in de Man, Rogosa and 
Sharpe (MRS) agar formulated in-house. Lucigen's DNA extraction kit (Quick Extraction) was 
used for DNA extraction from the colonies. The precise quantification of the extracted genomic 
DNA was measured using Nanodrop One (ThermoFisher Scientific). 
 
Droplet Digital LAMP Assay, ddLAMP 
 
For a first test run of the performance of our unit in ddLAMP, we amplified a final concentration 
of 20 ng/ mL of Lambda DNA using Calcein-MnCl2 mix (final concentration: Calcein 2500 µM, 
MnCl2 - 75mM) as non-specific fluorescent dye. The droplets were formed using the same oil mix 
described earlier and pumped with syringe pumps (Harvard Apparatus 22). For this experiment, 
cartridge with dimensions (H xW) of 100 µm x 50 µm was used. Bulk amplification of the same 
set up was set up for process control (Fig. 4.4 a). 
For the droplets, both the (no template controls) NTCs and test droplets were amplified. Confocal 
micrographs (Fig. 4.4 c) obtained from the amplified droplets were analyzed for fluorescence using 
earlier discussed methods using ImageJ. To establish a threshold, the mean NTC relative 
fluorescence units (RFU)  After amplification + 3*standard deviation was used. The obtained data 
was visualized (Fig. 4.4 b) using python scripting to quantify the positive droplets.  
 
Analysis of the data showed that 20% of the droplets generated from the positive sample stream 
were positive after amplification. With Lambda DNA length as 48502 bp and an average droplet 
volume of 98 pL (0.38 copies/ pL), based on Poisson, we would expect all the droplets to be 
positive. Principally, we calculated the actual concentration utilized in the amplification as we 
believed this was as a result of loss of DNA to the walls of the tubing. Hence to avoid this, we 
resorted to flushing the tubing and cartridge with 5mM bovine serum albumin (BSA) prior to 
ddLAMP run.  
From the analyzed data, we estimated that the actual DNA concentration used (or that made it into 









Fig 4.4 A. Bulk amplification of Lambda DNA used as a process control for the digital droplet 
LAMP B. Dot plot showing fluorescence signals from each distinct droplet used in ddLAMP  




Upon optimizing the ddLAMP protocols, a repeat using L. acidophilus was initiated. LAMP 
Master mix containing 1x isothermal amplification buffer, 8mM total of MgSO4, 1.4 mM dNTPs, 
320 U/ mL Bst 2.0 WarmStart polymerase, primer mix (1.6 µM each of FIP and BIP, 0.2 µM each 
of F3 and B3, 0.4 µM each of LF and LB), 1x SybrGreen was diluted with varying DNA 
concentrations. These dilutions yield 0, 1.56, 3.76, 7.48, and 60.47 DNA copies/ droplet coinciding 
with approx. 0, 25, 50, 75 and 100% positive droplet distributions per Poisson prediction. Before 





68oC for 60 minutes using Roche LC 96. All LAMP reagents were purchased from New England 
Biolabs (NEB) while the primers (Table 5) were designed in-house to target L. acidophilus 16S 
rRNA. 
 
Table 5  Lactobacillus  acidophilus primers 
 
 
Droplets from the microfluidic cartridges was collected in amber sepcap vials and incubated at 
68oC for 60 minutes using Multitherm incubator (Benchmark). Upon completion of the 
amplification step, the droplets were imaged using Leica SP5 confocal microscope and analyzed 
using image J to determine droplet RFU which are represented in Fig. 4.5.
Primer Sequence (5' - 3')
Lacid_FOP_TA TAA AGC GAG CGC AGG C
Lacid_BOP_TA CCT CAG CGT CAG TTG C
Lacid_FIP_TA CTG CAC TCA AGA AAA ACA GTT TCC GAG TCT GAT GTG AAA GCC CTC
Lacid_BIP_TA AAG AGG AGA GTG GAA CTC CAT GTG AGA CCA GAG AGC CGC CTT
Lacid_LoopF_TA GCA GTT CCT CGG TTA AGC C





























































Fig. 4.5. A Bulk amplification of dilutions using Roche LC 96 B. Figure showing correlation between Poisson predicted positive droplet and 
experimental data. C. Solid line shows expected fraction of positive droplets and how experimental data follows/ deviates from conventional 
expectations. D.    Post-amplification micrographs of droplets and the distribution of the droplets around the threshold. Threshold was 





Chapter 5. Encapsulation of Beads In Droplets 
 
Interests in using microparticles as delivery systems in various technologies have been widely 
researched, especially in combination with microdroplets for biological applications65–69. This is, 
in part, due to the high surface-to-volume ratio and the ease of immobilizing biorecognition 
molecules on them as well as the potential for compartmentalized single-molecule assays70–72. 
Single particle encapsulation in droplets, however, face two major challenges:  
 
• Sedimentation due to particle density69, and 
• Mechanistic single particle encapsulation73,74 
Offsetting Particle Density 
 
Particle density poses a challenge when loading microparticles into encapsulation devices 
because the higher density particles sediment in the syringe and delivery tubing, causing 
nonhomogeneous distribution of microparticles in droplets. This, however can be solved by the 
dissipation of the beads density by suspending them in denser fluids such as glycerol69. However, 
such fluids may not be compatible with the intended bio-application. For example, many 
applications use beads to separate biomolecules (proteins or nucleic acids)75,76, and in other 
downstream processes, such as nucleic acid amplification or detection68,77–80. The beads could be 
evenly distributed by matching the surrounding solution density with the bead density. However, 
increasing the buoyancy of microbeads by suspending them in such fluids (e.g. glycerol), which 
has a similar density as the microbeads (for example, 50% v/v glycerol – 50% less than what is 
required to improve buoyancy) inhibits LAMP, thereby defeating the purpose of the beads, Fig. 
5.1.   
To circumvent this challenge attendant to dense beads, many researchers68,72,81,82 used elastic 
packed/ gel beads which ensured a binary distribution of beads in the droplets without the 
challenges attendant to non-gel beads. This method is, however, time-consuming, requiring a 
particle velocity of ~50 µm/ hour73 or ~12 µL/ min to achieve single-particle encapsulation. 
More so, the use of smaller beads and channels with aspect ratios close to the particle diameter 
are other methods to ensure one particle per droplet. However, considering that these beads are 





beads may not carry enough binding capacity for the biomolecule of interest; fabricating < 50 
µm channels, from our experience is challenging and may mostly be feasible via sophisticated 
methods such as photolithography. 
Price et al69 presented a potentially simple solution by exploiting the sedimentation potential of 
the beads using a hopper system. They, however, showed that it took 0.8 h (17 µm Tetangel resin 
beads) and 3.8 h (2.8 µm magnetic beads) into bead introduction before achieving single bead 
encapsulation. Kim et al65 successfully developed a pneumatic system which is capable of 
trapping and releasing beads, thus creating a deterministic encapsulation of a defined number of 
beads per droplet. This system, however, is not simple to develop, thus, unfit for low-cost point-
of-care devices and for our application. 
Our goal is to present a simple, easy-to-develop solution to working with non-gel beads towards 
a more simplistic method of single bead encapsulation. In our system, we are confronted with 



















Fig. 5.1.  Denser fluids, such as glycerol may improve bead buoyancy but inhibit intended 
application (LAMP) Bead Density = 1.18 g/ cm3, Glycerol Density  = 1.26 g/ cm3. To offset the 
bead density, there is need to suspend the beads in 100% glycerol. What is the effect of such high 
concentration of glycerol in LAMP 
 
Another simple method is to vertically orient the syringe pump while keeping the beads 
suspended by mechanical agitation. Given the ease of adopting this solution, we embraced it for 
our system in order to improve the efficiency of bead/ particle encapsulation.  
 
Bead Suspension Via Mechanical Agitation 
 
To prevent loss of beads due to sedimentation in the flow tubing (Fig. 5.2 A) and in the syringe, 
we used a vertically actuated syringe pump system such that the content of the syringe is pumped 





stir bar inside the syringe is externally controlled using magnets on a DC motor (Fig. 5.2). Due to 





















Fig. 5.2 Top Left Beads are lost in flow tubing due to sedimentation. Top Right Using low torque 
mixing regime does not effectively suspend the beads leading to the encapsulation of multiple 
beads (Bottom) 
 
As an upgrade to the mixing and suspension of the beads, we designed and developed another 
simple system which uses a 4.5 Volts DC motor fixed inside a syringe to achieve mixing of the 






Design of The Mixing System 
 
A rotary device is used to make a 9mm hole in a 3mL syringe between the outlet and the 0.5 mL 
volume mark. Vibratory motor repurposed from a bead-beating sample preparation module 
(Claremont Bio) is inserted through the hole and glued using cold weld steel-reinforced epoxy (JB 
Weld). To ensure all crevices and air space at the motor-syringe interface are plugged, the syringe 
is capped, and a vacuum is created using the syringe plunger. When completely dried (48 – 72 
hours), the mixers are tested using a 4.5V battery pack before use in the actual experiment. 
 
During an experiment, the bead suspension is allowed to mix for about 5 minutes prior to 
dispensation to allow for an even mixture. As shown in Fig. 5.3, this led to an improvement in the 













Single Bead Encapsulation 
 
In principle, as particles move in microfluidic systems, they are acted upon by two major forces 
due to inertia which cause them to follow a streamline closest to their center of mass 
(equilibrium position). An implication of this system is a random arrangement of particles 
relative to each other. Particles could move side by side or one on top of another, etc. This is a 
major concern in single particle encapsulation which often results in Poisson distribution of the 
particles. We hypothesize that in order to achieve single particle encapsulation without the use of 
complex equipment and technologies, there is a need to create a single streamline for the 
particles thus forcing them to flow in single file. It is also important to control the spacing 
between the particles in order to avoid the waste of materials caused by the encapsulation of 
empty droplets. One method of achieving this is by making channels whose aspect ratio is close 
to the diameter of the particles of interest. Unfortunately, using our chosen method, 3D printing, 
printing features close to 20 µm is incredibly difficult. An alternative method is the use 
hydrodynamic focusing.  
 
Hydrodynamic Focusing in Microfluidic Systems 
 
The majority of microfluidic systems are 2-dimensional, leading to the squeezing of the 
dispersive fluid flow channel on both sides by sheath fluid83,84. While this squeeze reduces the 
width of this channel and changes the flow characteristics of the particles, it increases the aspect 
ratio of the channels because of its inability to focus the sample flow in the vertical direction84. 
Although promising, these methods increase the overall volumetric flow rate of the sample 
stream, thus, leading to the creation of large droplets unless a very high flowrate of oil is used. 
While this flow regime is not the most preferred, one of its primary goals is to control the 














Fig 5.4 Illustration of Hydrodynamic focusing and flow cell designed for its achievement 
 
 
𝑸𝒕𝒐𝒕𝒂𝒍 =  𝑽 ∗ 𝑨 , 𝑤ℎ𝑒𝑟𝑒 𝐴 = 𝑐𝑟𝑜𝑠𝑠 𝑠𝑒𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝑎𝑟𝑒𝑎, 𝑄 = 𝑣𝑜𝑙𝑢𝑚𝑒𝑡𝑟𝑖𝑐 𝑓𝑙𝑜𝑤 𝑟𝑎𝑡𝑒, 
 𝑉 = 𝑓𝑙𝑜𝑤 𝑣𝑒𝑙𝑜𝑐𝑖𝑡𝑦 




 ; where 𝑑2 = 𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟 + 𝑥 (𝑎𝑙𝑙𝑜𝑤𝑎𝑛𝑐𝑒) 
 
𝑄𝑡𝑜𝑡𝑎𝑙 =  𝑄𝑠ℎ𝑒𝑎𝑡ℎ +  𝑄𝑠𝑎𝑚𝑝𝑙𝑒 
 
𝑄𝑠ℎ𝑒𝑎𝑡ℎ = 0.125 ∗ 𝑉𝑠𝑎𝑚𝑝𝑙𝑒 ∗  𝜋 ∗ 𝐷2
2  













Using these relations, we can determine what flow regime is needed to derive the values for 
desired parameters.  
As mentioned, the use of a tributary dispersed phase to induce hydrodynamic focusing is 
effective but leads to the further dilution of the main sample stream within each droplet. 
Serendipitously, we realized that we could achieve hydrodynamic focusing without the use of 
tributary dispersed phases at a Qd/ Qc ≥ 100. This has not been reported anywhere to the best of 
our knowledge.  
While this is advantageous, it also presents challenges, in that the constriction of flow by the 
continuous phase creates a vortex such that beads and even dissolved solids would have to reach 
a critical mass before they can flow through. This concentrates the beads and could be 
responsible for the encapsulation of multiple beads. A video showing the described phenomenon 











Working Theory for Single Bead Encapsulation Using Continuous Phase Induced 
Hydrodynamic Focusing (Dubem Effect) 
 
Having successfully generated droplets using our system, we can deduce the rate of droplet 
formation per flow condition and consequently, the rate of query of the dispersed phase by the 
continuous phase at the point of confluence. Hence, we theorize that by equating the rate of droplet 
formation to the rate of bead introduction at the confluence point (Fig. 4.3 – Left), we can achieve 
single bead encapsulation. This theory, however, assumes 100% mixing and agglomeration break-
up efficiency of the in-syringe mixer and that the beads are introduced to the confluence as single 
beads and not as agglomerates. 
To test this, however, we needed to determine the rate of introduction of the beads to the 



















Fig 5.6 Part 1 Illustration of the Working Theory for Single Bead Encapsulation 
 
Number of droplets formed at point P per time 








𝑑𝑟𝑜𝑝𝑙𝑒𝑡 =  𝑏𝑒𝑎𝑑𝑠 
Number of beads queried at point P, per time: 




























Fig 5.6 Part 2 Illustration of the Working Theory for Single Bead Encapsulation 
 
 
Using this principle, settings and consumables described above we set up bead encapsulation 
experiments such that   = 1.47E-01 beads/ drolet (250 µL of transparent 20 µm beads at 5% solid 
in 1500 µL suspension). Using Poisson, we determined the predicted distribution of the beads. 
From experimental data, a total of 34 micrographs (2.63E+04 droplets) were analyzed manually 
to differentiate droplets with 0, 1, 2 and 3+ beads encapsulated. A comparison between the Poisson 
prediction and the experimental data shows a better performance than predicted with respect to 
single bead encapsulation. Although, more droplets than predicted had multiple beads in them, it 
is not understood if this is due to bead agglomeration or the Dubem effect as visualization could 
not be implemented with new set up. Figure 5.7 shows a comparison between our data and Poisson 
prediction. 
 
Time it would take for QC beads to get to point P = 
𝑸𝑪−𝟏 (𝑚𝑖𝑛𝑢𝑡𝑒 𝑏𝑒𝑎𝑑⁄ ) 
Distance, x(µm) between two successive beads  




Volume of droplet required for each droplet to 
encapsulate 1 bead each 
= Surface area of shaded part  (µ𝑚3) * X (µm) 
= A * V* 𝑸𝑪−𝟏  ,  but A*V = Q 
Droplet Volume = 𝑪−𝟏 (µ𝑚3) 













Fig 5.7. Our method generates more single bead droplets and fewer empty droplets than 
predicted by Poisson. 
 
 
Following the results from our protocols, we believe that by improving the mixing regime to 
prevent bead agglomeration and sedimentation, and optimizing the Dubem Effect, we may be 


























In this work, I set out to design platforms that would enable the application of LAMP in higher-
order multiplexing; as well as, develope enabling unit processes. Embodied within this written 
work are efforts geared at developing unit processes that would lead to the actualization of the 
primer payload system/ platform.  
 
By exploiting RNA chemistry, I designed a primer delivery system compatible with LAMP. In 
fact, data from the RNA-dependent primer delivery shows that the developed assay/ reagents 
improve LAMP speed compared to conventional LAMP systems. While this phenomenon, can be 
argued to only have been demonstrated using E. coli gDNA, it shows promise that upon 
optimization could be a unique improvement to LAMP chemistry.  
 
Using simplistic tools, I designed protocols and methods for the fabrication of microfluidic 
cartridges using 3D printing and soft lithography. I also developed   consumables, including 
reagents which enabled the generation of monodisperse picoliter scale droplets. These were later 
applied in droplet digital LAMP and dense bead encapsulation. 
 
Dense bead manipulation is a very difficult principle in the field of bead-based research. In fact, a 
lot of researchers prefer working with gel beads in order to improve yield (encapsulation 
efficiency). This underscored the importance to generate a working theory and consumables which 
would aid the encapsulation of single dense beads without the use of very expensive equipment. 
In the course of developing this, I serendipitously observed two important phenomena which 
affected working with the beads. These are the effect of curved flow focusing vertices which 
enabled the characteristic conversion of flow focusing droplet generation regime into co-flow. It 
led to a continuous phase-induced hydrodynamic focusing, thereby aiding laminar flow of the 
beads.  
A rather interesting but negative phenomenon emanating from this was the constriction of beads 
at the encapsulation neck. This resulted to the beads waiting to reach a critical mass before they 
are able to break through for encapsulation. Perhaps, this led to the encapsulation of more than one 





effective against dissolved solids which keep circling till a critical mass is reached. Although I do 
not yet know the cause of these serendipitous events, it is my hope that they can be exploited for 
future use in various fields, for example for concentration dissolved solids or as a filtration system 
or DNA concentration methods. 
 
In effect, I was able to address the questions which made up the body of this work and were 
highlighted in Chapter 1. 
1. Can we successfully functionalize the bead surfaces with the primers? 
Yes, I achieved this 
2. What mechanism can we use to ensure the primers are available in solution when needed? 
I developed a primer release system by exploiting RNA chemistry 
3. Can the surface-bound primers successfully hybridize target DNA? 
Yes, I demonstrated that bead-bound FIP could sequestrate DNA targets from solution 
4. Can we successfully create a microfluidic chip for bead encapsulation and ddLAMP? 
I designed and developed a microfluidic platform for this using 3D printing and soft 
lithography. It was successfully applied in ddLAMP 
5. How do we encapsulate only 1 bead per droplet without the use of very expensive tools? 
For this, I developed a working theory and consumables which can be further optimized for 
greater efficiency. At the moment, I recorded   >200% more single bead encapsulation than 
Poisson prediction and   reduced the abundance of empty droplets by 25%. 
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